Apple
AAPL
Oracle
ORCL
Adobe
ADBE
Ecopetrol
EC
D.R. Horton
DHI
US Stock MarketDetailed Quotes
RNAC Cartesian Therapeutics
- 16.920
- -1.390-7.59%
Close Dec 18 16:00 ET
- 17.990
- +1.070+6.32%
Pre 05:21 ET
430.02MMarket Cap-0.37P/E (TTM)
18.730High16.860Low212.89KVolume18.340Open18.310Pre Close3.75MTurnover2.43%Turnover RatioLossP/E (Static)25.41MShares41.87052wk High564.00P/B148.04MFloat Cap11.66552wk Low--Dividend TTM8.75MShs Float728.003Historical High--Div YieldTTM10.21%Amplitude11.665Historical Low17.631Avg Price1Lot Size
About Cartesian Therapeutics Company
Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company is headquartered in Gaithersburg, MD.
Company Profile
SymbolRNAC
Company NameCartesian Therapeutics
Listing DateJun 22, 2016
CEODr. Carsten Brunn, PhD
MarketNASDAQ
Employees38
Fiscal Year Ends12-31
Address704 Quince Orchard Road
CityGaithersburg
ProvinceMaryland
CountryUnited States of America
Zip Code20878
Phone1-617-923-1400
Company Executives
- Name
- Position
- Salary
- Dr. Carsten Brunn, PhD
- Director, President and Chief Executive Officer
- 6.11M
- Blaine Davis
- Chief Financial Officer and Principal Accounting Officer
- 2.49M
- Dr. Metin Kurtoglu, M.D.,PhD
- Chief Technology Officer
- 5.37K
- Dr. Christopher M. Jewell, PhD
- Chief Scientific Officer
- 53.10K
- Dr. Milos Miljkovic, M.D.
- Chief Medical Officer
- --
- Dr. Emily English, PhD
- Senior Vice President and Head of Manufacturing
- --
- Carrie S. Cox
- Chairman of the Board
- 292.32K
- Dr. Kemal Malik, M.B.B.S.
- Director
- --
- Dr. Timothy A. Springer, M.D.,PhD
- Director
- 192.73K
- Timothy C. Barabe
- Independent Director
- 212.93K
- Patrick J. Zenner
- Independent Director
- 192.05K
- Dr. Nishan de Silva, M.B.A.,M.D.
- Independent Director
- 188.58K
- Dr. Murat Kalayoglu, M.D.,PhD
- Independent Director
- --
- Dr. Michael Singer, M.D.,PhD
- Independent Director
- 5.71K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.